• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    HbA1c Testing Market

    ID: MRFR/HC/7045-CR
    134 Pages
    Kinjoll Dey
    October 2019

    HbA1c Testing  Market Research Report Information by Product (Instruments (Bench-Top Device and Handheld Device) and Reagents and Kits), By Technology (Ion-Exchange High-Performance Liquid Chromatography (HPLC), Turbidimetric Inhibition Immunoassay (TINIA), Enzymatic Assay and Others), By End User (Hospitals and Clinics, Diagnostic Laboratories and Others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    HbA1c Testing Market Infographic
    Purchase Options

    HbA1c Testing Market Summary

    As per Market Research Future Analysis, the HbA1c Testing Market was valued at USD 1.68 Billion in 2023 and is projected to reach USD 4.56 Billion by 2032, growing at a CAGR of 13.12% from 2024 to 2032. The market is driven by the rising prevalence of diabetes, advancements in testing technologies, and increasing healthcare infrastructure. The COVID-19 pandemic initially hindered testing volumes but has since led to a resurgence in demand. Key players in the market include Bio-Rad Laboratories, Abbott Laboratories, and Siemens Healthineers, among others.

    Key Market Trends & Highlights

    The HbA1c Testing Market is witnessing significant growth due to various factors.

    • Market Size in 2023: USD 1.68 Billion.
    • Projected Market Size by 2032: USD 4.56 Billion.
    • CAGR from 2024 to 2032: 13.12%.
    • Dominant Technology: Ion-exchange HPLC holds the largest market share.

    Market Size & Forecast

    2023 Market Size USD 1.68 Billion
    2024 Market Size USD 1.80 Billion
    2032 Market Size USD 4.56 Billion

    Major Players

    Bio-Rad Laboratories, Inc.; Abbott Laboratories; ARKRAY, Inc.; Danaher Corporation; Hoffmann-La Roche Ltd; Siemens Healthineers.

    HbA1c Testing Market Drivers

    Growing Aging Population

    The global aging population is a crucial driver of the Global HbA1c Testing Market Industry. As individuals age, the risk of developing diabetes increases, necessitating regular monitoring of blood glucose levels. By 2035, it is estimated that the number of older adults with diabetes will reach 300 million, further emphasizing the need for effective testing solutions. This demographic shift is likely to result in a heightened demand for HbA1c testing, as healthcare providers seek to manage the health of older patients more effectively. Consequently, the market is expected to expand significantly, reflecting the growing healthcare needs of an aging population.

    Market Growth Projections

    The Global HbA1c Testing Market Industry is projected to experience substantial growth, with estimates indicating a market value of 1.8 USD Billion in 2024 and a remarkable increase to 6.6 USD Billion by 2035. This growth trajectory suggests a robust demand for HbA1c testing solutions, driven by various factors including technological advancements, rising diabetes prevalence, and increased awareness of diabetes management. The compound annual growth rate of 12.54% from 2025 to 2035 further underscores the market's potential for expansion. These projections highlight the critical role that HbA1c testing will play in the ongoing efforts to manage diabetes effectively on a global scale.

    Rising Prevalence of Diabetes

    The increasing prevalence of diabetes globally drives the Global HbA1c Testing Market Industry. As of 2024, approximately 537 million adults are living with diabetes, a figure projected to rise significantly in the coming years. This surge necessitates regular monitoring of blood glucose levels, with HbA1c testing being a critical tool for managing diabetes. The demand for accurate and reliable testing methods is likely to grow, as healthcare providers emphasize the importance of maintaining optimal glycemic control to prevent complications. Consequently, the market is expected to expand, reflecting the urgent need for effective diabetes management solutions.

    Government Initiatives and Funding

    Government initiatives aimed at combating diabetes and promoting preventive healthcare are significantly influencing the Global HbA1c Testing Market Industry. Various countries are implementing programs to increase awareness about diabetes management and the importance of regular HbA1c testing. For example, public health campaigns and funding for diabetes education programs are being rolled out to encourage early diagnosis and treatment. These initiatives not only enhance public awareness but also facilitate access to testing services, thereby driving market growth. As governments continue to prioritize diabetes care, the market is likely to benefit from increased funding and resources dedicated to HbA1c testing.

    Technological Advancements in Testing

    Technological innovations in HbA1c testing methodologies are propelling the Global HbA1c Testing Market Industry forward. Newer devices and testing kits offer enhanced accuracy, faster results, and user-friendly interfaces, making them more appealing to both healthcare professionals and patients. For instance, point-of-care testing devices are gaining traction, allowing for immediate results in clinical settings. This shift towards more efficient testing solutions is likely to increase adoption rates, thereby contributing to market growth. As technology continues to evolve, the market is expected to witness a compound annual growth rate of 12.54% from 2025 to 2035, reflecting the ongoing demand for advanced testing options.

    Increased Awareness of Diabetes Management

    There is a growing awareness of the importance of diabetes management among patients and healthcare providers, which is positively impacting the Global HbA1c Testing Market Industry. Educational initiatives and resources are being developed to inform individuals about the significance of maintaining optimal HbA1c levels. This heightened awareness encourages patients to seek regular testing and adhere to treatment plans, ultimately leading to better health outcomes. As more individuals recognize the value of proactive diabetes management, the demand for HbA1c testing is likely to rise, contributing to the overall growth of the market.

    Market Segment Insights

    HbA1c Testing Technology Insights

    Based on the technology, the global hemoglobin testing market is classified into few types as ion-exchange HPLC, TINIA, enzymatic assay, and others. Out of these, ion-exchange HPLC is holding the largest market share for its high demand in the market. It is the most widely used testing kit that consumes less time, recognizes variants, and is also used in point-of-care settings. TINIA is expected to grow at a significant rate during the review period which offers the benefits like accurate results, cost-effectiveness, and quick-swiftness.

    HbA1c Testing Product Insights

    The global HbA1c testing machine market based on the product is bifurcated into two types as reagents & kits, and instruments. Further, the instruments are divided into a bench-top device and a handheld device.

    HbA1c Testing End-user Insights

    By end-user, the global HbA1c testing equipment market is analyzed into hospitals &clinics, diagnostic laboratories, and others. The hospitals &clinics segment is dominating the HbA1c testing market share due to the growing geriatric population worldwide.

    HbA1c Testing Region Insights

    Regionally, the global Hemoglobin testing machine market is categorized into four main geographies such as Europe, Asia-Pacific, America, and the Middle East & Africa. America is dominating the largest market share for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in emerging countries like the US and Canada.

    HbA1c Testing Market Regional Analysis

    Geographically, the HbA1c testing global market is divided into four major regions like Asia-Pacific, Europe, America, and the Middle East & Africa. Out of these regions, America is holding the leading position in the market of HbA1c testing for its rising activities like awareness campaigns, research, and joint ventures by public and private organizations in the US and Canada. Europe is predicted to hold the second-largest market share for their increasing adoption of advanced diagnostic tools and devices coupled with strategic activities like partnerships and agreements by the major key players is accelerating the market growth in this region.

    Get more detailed insights about HbA1c Testing Market Research Report - Forecast till 2032

    Key Companies in the HbA1c Testing Market market include

    Industry Developments

    February 2023:Bio-Rad Laboratories, Inc. (US) launched the D-100 Hemoglobin A1c assay, a high-performance liquid chromatography (HPLC) method offering accurate and precise HbA1c measurement on their D-Series analyzers. 

    August 2022:Transasia Bio-Medicals (India) received approval from the Indian Council of Medical Research (ICMR) for their HbA1c self-testing kit, marking a significant step towards increased accessibility in India.

    October 2023:Abbott Laboratories (US) received FDA clearance for the FreeStyle Libre 3 system, a continuous glucose monitoring (CGM) device offering 14-day wear and improved accuracy. While not directly an HbA1c test, CGM data can be used to estimate HbA1c levels.

    Future Outlook

    HbA1c Testing Market Future Outlook

    The HbA1c Testing Market is projected to grow at a 12.54% CAGR from 2024 to 2032, driven by technological advancements, increasing diabetes prevalence, and rising awareness of chronic disease management.

    New opportunities lie in:

    • Develop portable HbA1c testing devices for home use to enhance patient convenience. Invest in AI-driven analytics for personalized diabetes management solutions. Expand partnerships with healthcare providers to integrate HbA1c testing into routine check-ups.

    By 2035, the HbA1c Testing Market is expected to reach substantial growth, reflecting enhanced healthcare strategies and technological integration.

    Market Segmentation

    HbA1c Testing Region Outlook

    • {"Asia-Pacific"=>["China"
    • "Japan"
    • "India"
    • "Australia"
    • "South Korea"
    • "Rest of Asia-Pacific"]}
    • {"Rest of the World"=>["Middle East"
    • "Africa"
    • "Latin America"]}

    HbA1c Testing Product Outlook

    • Reagents & kits
    • Instruments

    HbA1c Testing End-user Outlook

    • Hospitals & clinics 
    • Diagnostic laboratories
    • others

    HbA1c Testing Technology Outlook

    • Ion-exchange HPLC
    • TINIA
    • enzymatic assay 
    • others

    Report Scope

    Report Attribute/MetricDetails
    Market Size 20231.68 (USD Billion)
    Market Size 20241.80 (USD Billion)
    Market Size 20324.56 (USD Billion)
    Compound Annual Growth Rate (CAGR)13.12 % (2024 - 2032)
    Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year2023
    Market Forecast Period2024 - 2032
    Historical Data2018-2022
      Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors  Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), ARKRAY, Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (US), Siemens Healthineers (US), Transasia Bio-Medicals (India), EKF Diagnostics (UK), Agappe Diagnostics Ltd (India), PTS Diagnostics (US), DiaSys Diagnostic Systems GmbH (Germany), CPC Diagnostics Pvt. Ltd. (India), Trinity Biotech PLC (Ireland), Rapid Diagnostics Group of Companies (India), and Tosoh India Pvt. Ltd. (India)
      Key Market Opportunities  Growing adoption of advanced diagnostic tools and devices coupled with the strategic activities such as partnerships and agreements by the prominent players
      Key Market DriversDeveloping healthcare infrastructure and increasing per capita disposable incomes Availability of new advanced treatment options

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    At what CAGR is the HbA1c Testing Market projected to grow during the forecast period?

    HbA1c Testing Market is projected to grow at a 13.12% CAGR between 2024-2032.

    Which region is expected to dominate the HbA1c Testing Market?

    The Americas is expected to dominate the HbA1c Testing Market.

    What will be the value of the HbA1c Testing Market during the forecast period?

    HbA1c Testing Market is predicted to touch USD 4.56 Billion by 2032.

    Which end user segment will lead the HbA1c Testing Market?

    The hospitals and clinics segment will lead the HbA1c Testing Market.

    Which product segment will dominate the HbA1c Testing Market?

    The reagents & kits segment will dominate the HbA1c Testing Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials